Search Results - "Hyun, Teresa"
-
1
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
Published in Clinical cancer research (15-01-2016)“…Cutaneous sclerosis occurs in 20% of patients with chronic graft-versus-host disease (GVHD) and can compromise mobility and quality of life. We conducted a…”
Get full text
Journal Article -
2
Phase 1 Study of ROR1 Specific CAR T Cells in Advanced Hematopoietic and Epithelial Malignancies
Published in Clinical cancer research (28-10-2024)“…The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is expressed in hematopoietic and epithelial cancers but has limited expression on normal adult…”
Get full text
Journal Article -
3
Disseminated adenovirus infection after autologous stem cell transplant
Published in Transplant infectious disease (01-02-2020)“…Adenovirus is an infrequent but challenging viral complication of transplantation that is rarely reported after autologous stem cell transplant. We present a…”
Get full text
Journal Article -
4
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
Published in Leukemia research (01-04-2017)“…Highlights • Dexamethasone alters mRNA translation independent of transcription in myeloma. • Dexamethasone treatment leads to translational repression of the…”
Get full text
Journal Article -
5
The Diagnostic Utility of D2-40, Calretinin, CK5/6, Desmin and MOC-31 in the Differentiation of Mesothelioma from Adenocarcinoma in Pleural Effusion Cytology
Published in Acta cytologica (01-01-2012)“…Objective: To evaluate the utility of the lymphatic endothelial marker D2-40, along with calretinin, CK5/6, desmin and MOC-31, in differentiating mesothelioma…”
Get full text
Journal Article -
6
KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation
Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)“…Bortezomib has been incorporated into thalidomide and dexamethasone provided with cisplatin, doxorubicin, cyclophosphamide, and etoposide (PACE) as an…”
Get full text
Journal Article -
7
Inflammatory Colitis after Treatment of Melanoma with Talimogene Laherparepvec (T-VEC)
Published in Journal of Immunotherapy and Precision Oncology (01-08-2018)“…Abstract Talimogene laherparepvec (T-VEC) is an intralesional oncolytic viral therapy for the treatment of recurrent, unresectable cutaneous, subcutaneous, and…”
Get full text
Journal Article -
8
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation
Published in Amyloid (01-12-2016)“…Introduction: High-dose melphalan and autologous stem cell transplantation (HDM/SCT) is an effective treatment modality for immunoglobulin light-chain (AL)…”
Get full text
Journal Article -
9
Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor
Published in Cancer research (Chicago, Ill.) (15-04-2007)“…Huntingtin interacting protein 1 (HIP1) is a multidomain oncoprotein whose expression correlates with increased epidermal growth factor receptor (EGFR) levels…”
Get full text
Journal Article -
10
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells
Published in Cancer cell (01-05-2003)“…The clathrin-associated protein, Huntingtin Interacting Protein 1 (HIP1), is overexpressed in multiple human epithelial tumors. Here, we report that HIP1 is a…”
Get full text
Journal Article -
11
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival
Published in The Journal of clinical investigation (01-08-2002)“…Huntingtin-interacting protein 1 (HIP1) is a cofactor in clathrin-mediated vesicle trafficking. It was first implicated in cancer biology as part of a…”
Get full text
Journal Article -
12
Whole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterations
Published in Communications biology (01-01-2018)“…While the incidence of esophageal adenocarcinoma (EAC) has risen drastically in Western countries over the last 40 years, a similar trend has not been observed…”
Get full text
Journal Article -
13
Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1
Published in Human molecular genetics (01-06-2007)“…The members of the huntingtin-interacting protein-1 (HIP1) family, HIP1 and HIP1-related (HIP1r), are multi-domain proteins that interact with inositol lipids,…”
Get full text
Journal Article -
14
HIP1 and HIP1r Stabilize Receptor Tyrosine Kinases and Bind 3-Phosphoinositides via Epsin N-terminal Homology Domains
Published in The Journal of biological chemistry (02-04-2004)“…Huntingtin-interacting protein 1-related (HIP1r) is the only known mammalian relative of huntingtin-interacting protein 1 (HIP1), a protein that transforms…”
Get full text
Journal Article -
15
HIP1: trafficking roles and regulation of tumorigenesis
Published in Trends in molecular medicine (01-04-2004)“…During recent years, alterations in proteins of the endocytic pathway have been associated with tumors. Disrupted regulation of the endocytic pathway is a…”
Get full text
Journal Article -
16
Aberrant huntingtin interacting protein 1 in lymphoid malignancies
Published in Cancer research (Chicago, Ill.) (15-09-2007)“…Huntingtin interacting protein 1 (HIP1) is an inositol lipid, clathrin, and actin binding protein that is overexpressed in a variety of epithelial…”
Get full text
Journal Article -
17
Utility of Bilateral Bone Marrow Biopsy Examination in Evaluation of Plasma Cell Myeloma
Published in American journal of clinical pathology (01-10-2015)“…Bilateral bone marrow biopsy evaluation is established in the staging of lymphoma and metastatic disease. Pathology reports for bilateral bone marrow biopsies…”
Get full text
Journal Article -
18
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy
Published in Biology of blood and marrow transplantation (01-07-2018)“…•Circulating plasma cells (CPCs) are a well-described risk factor in multiple myeloma.•The impact of CPCs at time of collection of autologous stem cells was…”
Get full text
Journal Article -
19
Hip1-related Mutant Mice Grow and Develop Normally but Have Accelerated Spinal Abnormalities and Dwarfism in the Absence of HIP1
Published in Molecular and Cellular Biology (01-05-2004)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
20
Pulmonary Presentation of Extramedullary Plasma Cell Myeloma: Postmortem Diagnosis
Published in American journal of clinical pathology (01-09-2016)Get full text
Journal Article